Outcome of children with refractory anaemia with excess of blast (RAEB) and RAEB in transformation (RAEB-T) in the Japanese MDS99 study.
Kikuchi A, Hasegawa D, Ohtsuka Y, Hamamoto K, Kojima S, Okamura J, Nakahata T, Manabe A; Japanese Paediatric Myelodysplastic Syndrome (MDS) Study Group.
Refractory anemia with excess of blasts in transformation. Clinical, hematologic, and cytogenetic findings in nine patients.
Smadja N, Krulik M, de Gramont A, Gonzalez-Canali G, Audebert AA, Debray J.
Cancer Genet Cytogenet. 1989 Oct 1;42(1):55-65. doi: 10.1016/0165-4608(89)90008-3.
PMID:2790747
Azacitidine versus decitabine in patients with refractory anemia with excess blast-Results of multicenter study.
Salim O, Toptas T, Avsar E, Yucel OK, Ozturk E, Ferhanoglu B, Geduk A, Mehtap O, Tombak A, Tiftik EN, Deveci B, Kurtoglu E, Kara O, Atagunduz IK, Tuglular TF, Undar L.
Characterization of clonogenic cells in refractory anemia with excess of blasts (RAEB-CFU): response to recombinant hematopoietic growth factors and maturation phenotypes.
Schouten HC, Delwel R, Bot FJ, Hagemeijer A, Touw IP, Löwenberg B.